Vaxart, Inc. VXRT
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 181.27M | 243.06M | 255.61M | 237.26M | 148.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 181.27M | 243.06M | 255.61M | 237.26M | 148.20M |
| Cost of Revenue | 131.15M | 184.26M | 200.25M | 201.58M | 179.08M |
| Gross Profit | 50.13M | 58.80M | 55.36M | 35.68M | -30.88M |
| SG&A Expenses | 19.98M | 19.19M | 17.18M | 17.61M | 17.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 151.13M | 203.45M | 217.43M | 219.18M | 197.05M |
| Operating Income | 30.14M | 39.61M | 38.18M | 18.07M | -48.84M |
| Income Before Tax | 29.76M | 39.01M | 37.51M | 16.80M | -50.40M |
| Income Tax Expenses | 714.00K | 419.00K | 410.00K | 476.00K | 308.00K |
| Earnings from Continuing Operations | 29.04 | 38.59 | 37.10 | 16.33 | -50.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.04M | 38.59M | 37.10M | 16.33M | -50.70M |
| EBIT | 30.14M | 39.61M | 38.18M | 18.07M | -48.84M |
| EBITDA | 35.34M | 45.62M | 45.64M | 26.65M | -40.08M |
| EPS Basic | 0.13 | 0.16 | 0.15 | 0.06 | -0.22 |
| Normalized Basic EPS | 0.08 | 0.10 | 0.10 | 0.04 | -0.14 |
| EPS Diluted | 0.12 | 0.16 | 0.15 | 0.06 | -0.22 |
| Normalized Diluted EPS | 0.08 | 0.10 | 0.10 | 0.04 | -0.14 |
| Average Basic Shares Outstanding | 961.82M | 947.60M | 933.80M | 921.08M | 912.80M |
| Average Diluted Shares Outstanding | 963.66M | 949.44M | 935.65M | 921.38M | 912.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |